Table 22: European 10-Year Perspective for Smoking Cessation Aids by Geographic Region - Percentage Breakdown of Dollar Sales for France, Germany, UK, Italy, Spain, Russia and Rest of Europe for the Years 2003, 2008 & 2012 (includes corresponding Graph/Chart) III-19
Table 21: European Long Term Projections for Smoking Cessation Aids by Product Segment - Nicotine Gum, Nicotine Patches, Lozenges & Tablets and Others Independently Analyzed by Annual Sales in US$ Million for the Years 2011 through 2015 (includes corresponding Graph/Chart) III-18
Table 20: European Recent Past, Current & Future Analysis for Smoking Cessation Aids by Product Segment - Nicotine Gum, Nicotine Patches, Lozenges & Tablets and Others Independently Analyzed by Annual Sales in US$ Million for the Years 2000 through 2010 (includes corresponding Graph/Chart) III-18
This report analyzes the worldwide markets for Smoking Cessation Aids in US$ Million.
SMOKING CESSATION AIDS MCP-1591 A GLOBAL STRATEGIC BUSINESS REPORT
Study Reliability and Reporting Limitations I-1 Disclaimers I-2 Data Interpretation & Reporting Level I-2 Quantitative Techniques & Analytics I-2 Product Definition and Scope of Study I-3 Smoking Cessation Aids I-3 Definitions I-3 A.
Product Overview II-12 Smoking Cessation Aids Defined II-12 Nicotine Gum II-12 Factors to Consider II-12 Effectiveness of Nicotine Gum II-13 Nicotine Patch II-13 Factors to Consider II-14 Nicotine Lozenges & Tablets II-14 Factors to Consider II-15 Other Smoking Cessation Aids II-15 Nicotine Inhaler II-15 Factors to Consider II-15 Nicotine Nasal Spray II-16 Factors to Consider II-16 Non-Nicotine Based Medications II-16
Trends and Issues II-17 Inundate Anti-Smoking Vaccines Kindles Underdeveloped Prescription Market II-17 Strict Regulations Deter Smoking Cessation Aids II-17 Growing Anti Smoking Campaigns II-18 Health Concerns II-18 Corporations Initiate for Smoke Free Work Environment II-18 Television Advertisements - Most Effective Media for Smoking Cessation II-19 Public Awareness through Internet II-19 Rising Prices of Tobacco - A Key Strategy for Quitting Smoking II-19
Without smoking cessation counseling and treatment, however, only five percent will succeed at overcoming their addiction.
The CDC recommends comprehensive smoking cessation benefits that include:
By providing the CDC-recommended smoking cessation benefits and additional support and incentives, we've helped 47 percent of CSX participants quit smoking successfully," said Kenneth Glover, director of health and wellness at CSX Transportation.
The Florida Institute for Smoking Cessation is a joint project of the Florida Academy of Family Physicians, the American Lung Association of the Southeast and several other public health, policy and business leaders who have joined together to educate, inform and build consensus among employers, government and health care providers for making smoking cessation assistance accessible to all smokers who want to quit.